R&D On the power of T-cells, with Cedrik Britten Dr Cedrik Britten, chief medical officer at Immatics, discusses novel PRAME-directed T-cell immunotherapies.
R&D JP Morgan 2023 – Alexandre LeVert Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs
Events Partner Content 4th Annual Cell Engager Summit | May 24-26 | Boston, MA Learn from the pioneers of immunotherapy
Events Partner Content Cell-Mediated Therapies for Infectious Disease Summit Cell-Mediated Therapies for Infectious Disease Summit
Oncology ASCO 2026: Powerful evidence for the microbiome in oncology,... Can the state of someone’s gut microbiome – the balance of good and bad bacteria in their digestive tract – affect their response to cancer immunother
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
